GERN : Summary for Geron Corporation - Yahoo Finance

U.S. Markets open in 9 hrs 24 mins

Geron Corporation (GERN)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
2.24+0.02 (+0.90%)
At close: 4:00PM EDT
People also watch
STEMARIAINCYEXELCTIC
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close2.22
Open2.22
Bid2.10 x 2000
Ask2.54 x 800
Day's Range2.21 - 2.38
52 Week Range1.81 - 3.35
Volume2,080,694
Avg. Volume1,452,637
Market Cap356.52M
Beta3.32
PE Ratio (TTM)-11.79
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube2 days ago

    ETFs with exposure to Geron Corp. : March 27, 2017

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to Geron Corp. Here are 5 ETFs with the largest exposure to GERN-US. Comparing the performance and risk of Geron Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Geron Corp. breached its 50 day moving average in a Bullish Manner : GERN-US : March 27, 2017
    Capital Cube3 days ago

    Geron Corp. breached its 50 day moving average in a Bullish Manner : GERN-US : March 27, 2017

    Categories: ETFs Yahoo Finance Click here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Geron Corp.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average ... Read more (Read more...)

  • Accesswire10 days ago

    Today's Research Reports on Stocks to Watch: Geron and Galena Biopharma

    NEW YORK, NY / ACCESSWIRE / March 20, 2017 / As both Geron and Galena Biopharma show signs of biotech life with their FDA trial advancements, the stocks also have a common problem – how to convince investors ...